Genentech Expands Oregon Fill/Finish Site
Genentech plans to invest more than $125 million in an expansion of its fill/finish facility in Hillsboro, OR.
Genentech announced on March 26, 2015 that it would invest more than $125 million in an expansion of its fill/finish facility in Hillsboro, OR. The fill/finish facility, which opened in April 2010, is currently home to warehousing and distribution. An increased demand for sterile products in Genentech’s pipeline necessitated an expansion to include the capacity for manufacturing, the company reports.
"This investment in our sterile production operations will result in the addition of up to 100 new skilled manufacturing jobs in the greater Portland area over the next five years, potentially bringing the total number of Genentech jobs in Oregon to over 500," said Larry Sanders, general manager and vice president, Hillsboro Technical Operations, in a press release.
Source: Genentech
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
